NCT06573983 Fall Risk Identification and Management for Older Veterans
| NCT ID | NCT06573983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Fall Risk |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2025-02-04 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2025-02-04 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Falls are a common occurrence among older adults, and Veterans have an even higher risk of falling compared to non-Veterans. These falls often lead to severe health consequences, including traumatic brain injuries, hip fractures, emergency visits, hospitalizations, and even death. It is crucial to prioritize fall prevention in order to reduce injuries and enable older Veterans to age comfortably at home. Although current fall prevention programs in the Veterans Health Administration primarily focus on inpatient care and nursing homes, there is a pressing need to address falls among older Veterans living independently in the community. The proposed VA-specific Fall Risk Identification and Management (FRIM) model aims to proactively prevent falls in older Veterans who receive primary care, effectively reducing the occurrence of adverse health events associated with falls. By placing emphasis on prevention rather than reacting after falls have already happened, this initiative seeks to significantly enhance the overall well-being of older Veterans.
Eligibility Criteria
Inclusion Criteria: * Receives care within GeriPACT, or general PACT as needed (Aim 1); Receives care within general PACT (standard VHA primary care) (Aim 2) * Screens positive for increased fall risk (answers "yes" to any of 3 screening questions) * Positive screen on at least two fall risk factor assessments (Aim 1); Positive screen on at least one fall risk factor assessment (Aim 2) * Access to telehealth * Availability of an additional adult (e.g., caregiver or family member) to be present during the physical assessment Exclusion Criteria: * Life expectancy \<12 months, as determined by PCP * Neurological diagnosis (e.g., cerebral vascular accident, multiple sclerosis, Parkinson's Disease) * Moderate cognitive impairment (\<13 on telephone Montreal Cognitive Assessment (MoCA-BLIND) or \<18 on MoCA Full administered during clinic visit in the previous 3 months) * Unstable condition that precludes safe participation in structured exercise (e.g., recent deep vein thrombosis) if expected fall risk factor is physical, as determined by PCP or chart review * Participation in any intervention components of the FRIM model, with the intention of reducing a FRIM fall risk factor, within the past 2 months * Currently using a wheelchair for mobilization * If it is in the opinion of the study staff that the participant would be at an increased suicide risk due to study procedures
Contact & Investigator
Alexander J Garbin, PhD DPT
PRINCIPAL INVESTIGATOR
Rocky Mountain Regional VA Medical Center, Aurora, CO
Frequently Asked Questions
Who can join the NCT06573983 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Fall Risk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06573983 currently recruiting?
Yes, NCT06573983 is actively recruiting participants. Contact the research team at Alexander.Garbin@va.gov for enrollment information.
Where is the NCT06573983 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT06573983 clinical trial?
NCT06573983 is sponsored by VA Office of Research and Development. The principal investigator is Alexander J Garbin, PhD DPT at Rocky Mountain Regional VA Medical Center, Aurora, CO. The trial plans to enroll 108 participants.